Search by Drug Name or NDC
NDC 43066-0016-10 CARDENE IV 0.2 mg/mL Details
CARDENE IV 0.2 mg/mL
CARDENE IV is a INTRAVENOUS INJECTION, SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Baxter Healthcare Corporation. The primary component is NICARDIPINE HYDROCHLORIDE.
Product Information
| NDC | 43066-0016 |
|---|---|
| Product ID | 43066-016_f95d328e-964b-4540-9f59-0b1507b63947 |
| Associated GPIs | 34000018142040 |
| GCN Sequence Number | 064611 |
| GCN Sequence Number Description | nicardipine in NaCl, iso-osm PIGGYBACK 40MG/200ML INTRAVEN |
| HIC3 | A9A |
| HIC3 Description | CALCIUM CHANNEL BLOCKING AGENTS |
| GCN | 15826 |
| HICL Sequence Number | 035779 |
| HICL Sequence Number Description | NICARDIPINE IN SODIUM CHLORIDE, ISO-OSMOTIC |
| Brand/Generic | Brand |
| Proprietary Name | CARDENE IV |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | nicardipine hydrochloride |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | INJECTION, SOLUTION |
| Route | INTRAVENOUS |
| Active Ingredient Strength | 0.2 |
| Active Ingredient Units | mg/mL |
| Substance Name | NICARDIPINE HYDROCHLORIDE |
| Labeler Name | Baxter Healthcare Corporation |
| Pharmaceutical Class | Calcium Channel Antagonists [MoA], Cytochrome P450 2C19 Inhibitors [MoA], Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS |
| DEA Schedule | n/a |
| Marketing Category | NDA |
| Application Number | NDA019734 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 43066-0016-10 (43066001610)
| NDC Package Code | 43066-016-10 |
|---|---|
| Billing NDC | 43066001610 |
| Package | 10 BAG in 1 CARTON (43066-016-10) / 200 mL in 1 BAG |
| Marketing Start Date | 2020-10-26 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |